Terumo Cardiovascular Group

e-mail usprint

Autotransfusion

Fresenius C.A.T.S (Continuous AutoTransfusion System), the only available continuous flow autotransfusion technology, is distributed exclusively in the U.S. by Terumo Cardiovascular Group.

Information provided on this website is not intended to make claims that the products are safe and effective for any use other than those explicitly described in the Instructions for Use. Clinicians should refer to the Instructions for Use or Owner's Manuals for complete information on the intended use of any product mentioned in this website.

ABSTRACT: Intraoperative Autotransfusion in Small Children: An In-vitro Investigation to Study its Feasability. Anesth Analg, April 1999; 88(4): 763-6. Booke, et al.
This in-vitro study demonstrates the ability of the Fresenius C.A.T.S System to produce high quality HCT independent of blood volume suggesting the feasability of IAT in small children.

ABSTRACT: Continuous-Flow Cell Saver Reduces Cognitive Decline in Elderly Patients After Coronary Bypass Surgery. Circulation. 2007;116:1888-1895. Djaiani et al.
In this 226-patient randomized, double-blinded study, the use of the Fresenius C.A.T.S System to process shed blood showed less post-operative cognitive dysfunction than those using unprocessed shed blood.

ABSTRACT: Quality of Processed Blood for Autotransfusion. JECT March 2000; 32: 11-9. Shulman, et al.
The authors evaluate the quality of processed blood using several parameters and demonstrate that the C.A.T.S System has a high washout efficiency and produces consistently high HCT at high flow rates.

ABSTRACT: Qualitative Assessment of Blood Washing with the Continuous Autologous Transfusion System (CATS). Int J Art Org, April 1997; 20: 234-9. Walpoth, et al.
In this prospective study, the authors consistently found HCT of 62% and elimination rates greater than 93% for plasma components using the Fresenius C.A.T.S System.

ABSTRACT: Blood Separation with Two Different Autotransfusion Devices: Effects on Blood Cell Quality and Coagulation Variables. Int. J Artif Organs, Dec 1998; 2: 820-4. Rosalski, et al.
The authors compare the Fresenius C.A.T.S System with another device and found that C.A.T.S had a higher platelet recovery rate and higher platelet concentration.